DGRW: Pfizer’s Vaccine News Could Set This ETF Into Motion

  • The WisdomTree U.S. Quality Dividend Growth ETF ( DGRW ) focuses on the dividend growth & quality factors and could be uniquely positioned to outperform in a post-vaccine world Positioning For The Re-Opening Rally The news of Pfizer’s potential coronavirus vaccine yielding very encouraging results in the early findings of its clinical trial was more than enough to send investors racing into risk assets betting that a full economic recovery could be on the way.
  • Instead, DGRW looks at long-term earnings growth expectations as a proxy for a company’s ability to continue paying and growing its dividend over time.

Source: DGRW: Pfizer’s Vaccine News Could Set This ETF Into Motion

Leave a Reply